TOP TIERMARKET NEWSWIRE
News & sentiment

AKARI THERAPEUTICS P ADR (AKTX) — News & AI sentiment

AKARI THERAPEUTICS P ADR (AKTX) news roundup. 1 story in the past week, 7 over 30 days. Average 30-day sentiment is 61.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 63/100
30d stories
7
avg sentiment 61.3/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on AKTX

6d ago
Jul 22
Jul 21
Jul 13
Jul 7
Jul 7
Akari Therapeutics Plc (AKTX) files 8-K
SEC 8-K50 · neutralgeneral
Jul 2
Jun 29
Akari Therapeutics Plc (AKTX) files 8-K
SEC 8-K50 · neutralgeneral
Jun 26
Jun 4
May 28
May 28
May 22
May 22
May 22
May 22
May 22
May 21
May 21
May 21
May 21
May 18
Open AKTX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →